1. Home
  2. ALGS vs LSF Comparison

ALGS vs LSF Comparison

Compare ALGS & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • LSF
  • Stock Information
  • Founded
  • ALGS 2018
  • LSF 2015
  • Country
  • ALGS United States
  • LSF United States
  • Employees
  • ALGS N/A
  • LSF N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • LSF Packaged Foods
  • Sector
  • ALGS Health Care
  • LSF Consumer Staples
  • Exchange
  • ALGS Nasdaq
  • LSF Nasdaq
  • Market Cap
  • ALGS 64.8M
  • LSF 62.0M
  • IPO Year
  • ALGS 2020
  • LSF 2020
  • Fundamental
  • Price
  • ALGS $7.21
  • LSF $4.58
  • Analyst Decision
  • ALGS Strong Buy
  • LSF Strong Buy
  • Analyst Count
  • ALGS 2
  • LSF 2
  • Target Price
  • ALGS $60.00
  • LSF $12.00
  • AVG Volume (30 Days)
  • ALGS 99.6K
  • LSF 33.4K
  • Earning Date
  • ALGS 11-06-2025
  • LSF 11-10-2025
  • Dividend Yield
  • ALGS N/A
  • LSF N/A
  • EPS Growth
  • ALGS N/A
  • LSF N/A
  • EPS
  • ALGS N/A
  • LSF N/A
  • Revenue
  • ALGS $3,174,000.00
  • LSF $47,027,546.00
  • Revenue This Year
  • ALGS N/A
  • LSF $21.88
  • Revenue Next Year
  • ALGS N/A
  • LSF $20.86
  • P/E Ratio
  • ALGS N/A
  • LSF N/A
  • Revenue Growth
  • ALGS N/A
  • LSF 22.79
  • 52 Week Low
  • ALGS $3.76
  • LSF $4.42
  • 52 Week High
  • ALGS $46.80
  • LSF $10.90
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 28.33
  • LSF 33.06
  • Support Level
  • ALGS $9.25
  • LSF $4.50
  • Resistance Level
  • ALGS $8.76
  • LSF $5.06
  • Average True Range (ATR)
  • ALGS 0.77
  • LSF 0.32
  • MACD
  • ALGS -0.30
  • LSF -0.01
  • Stochastic Oscillator
  • ALGS 2.68
  • LSF 8.33

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Share on Social Networks: